Technology | September 03, 2009

Next-Generation FoxCross PTA Catheter Aimed at PAD


The FoxCross PTA Catheter is a next-generation .035 balloon dilatation catheter is used to open peripheral arteries that have become blocked with plaque. The system is available in a wide variety of diameters (3-14 mm), balloon lengths (20-120 mm), and catheter lengths (50 cm, 80 cm and 135 cm) on an over-the-wire delivery platform.

The catheter is said to be highly-deliverable and offers superb crossability and impressive deflation times.

FoxCross is a highly deliverable balloon dilatation catheter designed to optimize
the treatment of patients with PAD during angioplasty procedures. It incorporates technological advancements such as the JETCOAT coating that allows for smooth device movement and enhanced deliverability, streamlined tip and crossing profile for accessing and treating challenging lesions, and a dual-lumen shaft with large, crescent-shaped contrast lumen for rapid inflation/deflation

The FoxCross released in the United States in May 2009.

For more information: www.abbott.com.


Related Content

News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
News | Balloon Catheter

July 15, 2019 — Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon ...

Home July 15, 2019
Home
Subscribe Now